Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-27,006
Closed -$4.4M 59
2024
Q4
$4.4M Buy
+27,006
New +$4.83M 1.35% 34
2023
Q2
Sell
-17,758
Closed -$2.96M 56
2023
Q1
$2.96M Sell
17,758
-649
-4% -$106K 1.49% 30
2022
Q4
$2.7M Buy
18,407
+2,902
+19% +$429K 1.58% 30
2022
Q3
$2.3M Buy
15,505
+691
+5% +$115K 1.51% 30
2022
Q2
$2.55M Buy
14,814
+352
+2% +$60.9K 1.75% 24
2022
Q1
$2.73M Buy
+14,462
New +$2.86M 1.77% 31

Other funds holding ZTS

Legacy CG's ZTS Position: Q1 2025 in Review

Legacy CG sold out of Zoetis (ZTS) in Q1 2025, closing a stake of 27,006 shares — an estimated $4.4M sold.

Legacy CG first reported a position in ZTS in Q1 2022 and held it in 6 quarters. The position peaked at $4.4M in Q4 2024. 1,890 funds tracked by Wall St. Rank hold ZTS as of Q1 2025.

  • Legacy CG reported no remaining Zoetis position as of Q1 2025 after selling out during the quarter.
  • Legacy CG sold 27,006 Zoetis shares in Q1 2025, an estimated $4.4M.
  • Legacy CG first reported a position in Zoetis in Q1 2022 and held it in 6 quarters.
  • Legacy CG's Zoetis position peaked at $4.4M in Q4 2024.
  • 1,890 funds tracked by Wall St. Rank held Zoetis as of Q1 2025.

Based on Legacy CG's 13F filing for Q1 2025, filed 24 Apr 2025.